financetom
Business
financetom
/
Business
/
Website creator Wix.com tops Q2 estimates, sees strong second half
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Website creator Wix.com tops Q2 estimates, sees strong second half
Aug 7, 2024 6:32 AM

JERUSALEM, Aug 7 (Reuters) - Wix.com ( WIX ) beat

second-quarter net profit expectations on Wednesday boosted by

price hikes and its artificial intelligence (AI) and Studio

products for designing advanced websites.

The Israeli company posted earnings of $1.67 per diluted

share, excluding one-time items, up from $1.26 cents per share a

year earlier. Revenue for the April-June quarter grew 12% to

$436 million.

Analysts expected Wix to earn $1.35 per share excluding

one-time items on revenue of $434 million, LSEG data showed.

Wix raised its full-year revenue outlook to $1.747-$1.761

billion, for annual growth of up to 13%. It expects

third-quarter revenue of $440-$445 million, up 12-13%.

Analysts are currently forecasting revenue of $443 million

in the third quarter and $1.75 billion in 2024.

Wix also said it would achieve the Rule of 40 - where its

combined sales growth and profit margin exceeds 40% - later in

2024.

Chief Financial Officer Lior Shemesh said he expects revenue

growth of about 16% in the second half, driven by its Studio

product, which is being used by an increasing number of web

design agencies.

"We see existing agencies and partners keep on building...

second, third and fourth websites, which obviously provide us

with a kind of compounding effect on the revenue coming from

partners," he also told a news conference.

Price increases earlier in the year have not hurt the

company since Wix also launched new features and products,

Shemesh said, noting that AI offerings were boosting customer

numbers.

"This is what provides us with the confidence that we see a

further acceleration in the second half of the year," he said.

Wix's Nasdaq-listed shares were up 5% at $164.90 in

pre-market trading. They have risen 28% so far in 2024.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Geron Prices $150 Million Offering of Shares, Pre-Funded Warrants
Geron Prices $150 Million Offering of Shares, Pre-Funded Warrants
Mar 19, 2024
10:37 AM EDT, 03/19/2024 (MT Newswires) -- Geron ( GERN ) said Tuesday it priced an underwritten offering of about 42 million shares and about 8 million pre-funded warrants at $3 per share and $2.999 per pre-funded warrant for gross proceeds of about $150 million. Net proceeds from the offering, along with existing cash, cash equivalents and current and noncurrent...
R1 RCM Calls for Halt to Talks About Potential Deal
R1 RCM Calls for Halt to Talks About Potential Deal
Mar 19, 2024
10:37 AM EDT, 03/19/2024 (MT Newswires) -- R1 RCM ( RCM ) said Tuesday that a special committee of independent directors called for a halt to talks between New Mountain Capital and TCP-ASC ACHI about a potential deal with respect to the company. As such, the special committee has not approved at this time any of the standstill waivers requested...
Morphic Holding Names Simon Cooper as Chief Medical Officer
Morphic Holding Names Simon Cooper as Chief Medical Officer
Mar 19, 2024
10:38 AM EDT, 03/19/2024 (MT Newswires) -- Morphic Holding ( MORF ) said Tuesday that Simon Cooper has joined the company as its chief medical officer. Cooper previously held the same role at Keros Therapeutics ( KROS ) , according to Morphic ( MORF ). Price: 34.17, Change: +0.71, Percent Change: +2.12 ...
Fate Therapeutics Prices $100 Million Offering, Private Placement
Fate Therapeutics Prices $100 Million Offering, Private Placement
Mar 19, 2024
10:44 AM EDT, 03/19/2024 (MT Newswires) -- Fate Therapeutics ( FATE ) said Tuesday it has priced an underwritten offering of about 14.5 million shares at $5.50 per share. The company also priced a concurrent private placement of pre-funded warrants to buy about 3.6 million shares at $5.499 per pre-funded warrants. Gross proceeds from the offering and private placement are...
Copyright 2023-2026 - www.financetom.com All Rights Reserved